BackChemours Company Overview
Chemours Company

Chemours Company Target Price

Analysts' average 12-month price target for Chemours Company is $19.

Get informed when a big investor buys or sells

+ Follow

Share Price

$14.53

Average Target Price

$19.1731.9% upside

6 analysts in the last 4 months

High: $22 | Low: $17

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-13BMO Capital$1823.9% upsideOpen
2026-08-13Goldman SachsDuffy Fischer$1717% upsideOpen
2026-08-10Morgan StanleyVincent Andrews$1823.9% upsideOpen
2026-08-10UBSJoshua Spector$1823.9% upsideOpen
2026-08-06RBC Capital$2251.4% upsideOpen
2026-08-05Mizuho Securities$2251.4% upsideOpen
2026-05-13Alembic Global$30106.5% upsideOpen
2026-05-11Morgan StanleyVincent Andrews$2144.5% upsideOpen
2026-05-11RBC Capital$2999.6% upsideOpen
2026-05-08UBS$30106.5% upsideOpen
2026-05-06Mizuho SecuritiesJohn Roberts$30106.5% upsideOpen
2026-04-28Truist FinancialPeter Osterland$30106.5% upsideOpen
2026-04-10RBC CapitalArun Viswanathan$2678.9% upsideOpen
2026-04-09UBS$2999.6% upsideOpen
2026-04-09Truist Financial$2785.8% upsideOpen
2026-02-23JefferiesLaurence Alexander$1717% upsideOpen
2026-02-23UBS$2358.3% upsideOpen
2026-02-23BMO Capital$1930.8% upsideOpen
2026-02-23Mizuho Securities$1717% upsideOpen
2026-02-23Morgan StanleyVincent Andrews$1717% upsideOpen
2026-01-21Truist Financial$2144.5% upsideOpen
2026-01-19BMO CapitalJohn McNulty$2037.6% upsideOpen
2026-01-16RBC Capital$1823.9% upsideOpen
2025-11-10Truist FinancialPeter Osterland$1823.9% upsideOpen
2025-10-16Mizuho SecuritiesJohn Roberts$1823.9% upsideOpen
2025-10-14RBC Capital$1930.8% upsideOpen
2025-10-06UBSJoshua Spector$2144.5% upsideOpen
2025-09-23Mizuho SecuritiesJohn Roberts$1930.8% upsideOpen
2025-05-07UBSJoshua Spector$1717% upsideOpen
2025-04-15Mizuho SecuritiesJohn Roberts$153.2% upsideOpen
2024-10-11RBC CapitalArun Viswanathan$2892.7% upsideOpen
2024-10-07BMO CapitalJohn McNulty$32120.2% upsideOpen
2024-08-06BMO CapitalJohn McNulty$30106.5% upsideOpen
2024-06-07Mizuho SecuritiesJohn Roberts$2572.1% upsideOpen
2024-05-29UBSRich Hilliker$31113.4% upsideOpen
2024-04-09BMO CapitalJohn McNulty$34134% upsideOpen
2024-04-01UBSJoshua Spector$2892.7% upsideOpen
2024-04-01CFRAEmily Nassedd Mitsch$1823.9% upsideOpen
2024-03-13D.A. DavidsonLinda Bolton Weiser$2465.2% upsideOpen
2023-12-01RBC CapitalArun Viswanathan$40175.3% upsideOpen
2023-10-30Morgan StanleyVincent Andrews$33127.1% upsideOpen
2023-01-10RBC CapitalArun Viswanathan$33127.1% upsideOpen
2022-05-04RBC Capital$48230.4% upsideOpen
2021-05-20Bank of America SecuritiesMatthew DeYoe$42189.1% upsideOpen
2021-05-10Morgan StanleyVincent Andrews$35140.9% upsideOpen
2021-05-06Argus ResearchDavid Coleman$40175.3% upsideOpen

Chemours Company (CC) FAQ

Chemours Company posts a target price of $19. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $19 for CC means covering analysts, on average, see the stock 31.9% upside of $14.53 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for CC's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Chemours Company's other metric pages and overview cover the third.

Judging Chemours Company against Consumer Discretionary peers is usually better than using a market-wide rule of thumb. Business models inside Consumer Discretionary are more comparable, which makes gaps in target price easier to interpret. Start with $19 here, then scan peer and history charts to see if the gap is persistent.